Abstract: Context: Standard WHO-ORS reduces dehydration, but does not reduce stool volume and duration of diarrhea. Low osmolar ORS produce maximal water absorption. This meta-analysis was conducted to evaluate the efficacy of low osmolar ORS in comparison to standard WHO-ORS. Evidence acquisition: A systematic review and meta-analysis of Randomized Controlled Trials (RCTs) comparing efficacy of low osmolar ORS and standard WHO-ORS in childhood diarrhea was carried out. RCTs were searched in PubMed, Cochrane CENTRAL, DOAJ, Google Scholar and Google. The data was extracted in Excel and entered in Review Manager 5.3 for calculation of effect sizes. Results: The outcome of stool output was reported in 9 trails. Reduced osmolarity ORS resulted in significantly reduced stool output as compared with standard WHO-ORS (pooled standardized mean difference -0.44, 95% CI -0.72 to -0.15). Information for the outcome of duration of diarrhea was available from 6 trials. The pooled standardized mean difference was -0.21 (95% CI -0.79 to 0.37), suggesting that reduced osmolarity ORS did not have significant effect on the duration of diarrhea as compared to standard WHO-ORS. The outcome of need for intravenous fluid therapy was reported in 8 trials. The meta-analysis revealed that reduced osmolarity ORS when compared to WHO standard ORS was associated with fewer unscheduled intravenous infusions (Odds Ratio 0.62, 95% CI 0.47 to 0.83). The meta-analysis for the outcome of vomiting reported in 5 clinical trials showed that children treated with low osmolar ORS were less likely to vomit than children treated with standard WHO-ORS (Odds Ratio 0.74, 95% CI 0.57 to 0.97). Conclusion: Low osmolar ORS when compared to standard WHO-ORS is associated with reduced stool output, reduction in need for unscheduled intravenous infusion and lesser episodes of vomiting. However, there was no significant difference in duration of diarrhea
stool output, vomiting episodes and duration of diarrhea through meta-analysis of randomized controlled trials.
Evidence Acquisition
Criteria for considering studies for review: Studies: Randomized controlled trials were included in this review (quasi-randomized trials were excluded). Participants: Children presenting with a complaint of diarrhea were included in this review. Adults were excluded from this review as the authors opined that ORS distribution in the public health facilities is mainly concentrated on children. Interventions: Trials comparing low osmolar ORS (osmolarity 250 mmol/L or less) with standard WHO-ORS (90 mmol/L sodium, 111 mmol/L glucose, total osmolarity 311 mmol/L). Outcomes: Pre-defined outcomes were stool output, duration of diarrhea, episodes of vomiting and intravenous fluid therapy during the course of treatment. Search strategy for documentation of studies: Clinical trials were searched in PubMed, Cochrane CENTRAL, DOAJ, Google Scholar and Google. The detailed search strategy used in PubMed and Cochrane CENTRAL is mentioned in Table 1 . The review is updated till September 2013. Data collection and analysis Selection of studies: The search was done by the first author. First and second author examined the abstracts independently for inclusion and exclusion from the review. Any differences were resolved by discussion with the third author. Assessment of risk of bias was carried out as per the guidelines of Cochrane Handbook for Systematic Reviews of Interventions. [5] Statistics: The data was extracted by first and second author and was maintained in Microsoft Excel software. The continuous data were log transformed into converted means as described in the Cochrane Handbook for Systematic Reviews of Interventions. [5] The dichotomous data were entered as it is. Data were then entered in Review Manager software version 5.3 and effect sizes were calculated. Dichotomous data (episodes of vomiting and need for intravenous infusion) were pooled in the form of Odds Ratio (with 95% CI) and continuous data (stool output and duration of diarrhea) were pooled in the form of standardized mean difference (with 95% CI).
Results
A total of 12 RCTs were included in the meta-analysis. The Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) flow diagram recording the selection of trials and reasons for exclusion is demonstrated in Figure 1 .
[6]
Figure 1: Flow diagram recording the selection of trials and reasons for exclusion
The characteristics of included studies are elaborated in Table 2 . 
Intravenous fluid (ml/kg) The characteristics of excluded studies with the reasons for exclusion are illustrated in Table 3 . Included 12-60 years subjects (adults also)
The risk of bias in each clinical trial included in the metaanalysis is elucidated in Table 4 . Funnel plot to assess publication bias was not plotted as the number of clinical trials in each outcome was less than 10.
Information for the outcome of stool output was available from 9 trails (n=2261) [ Figure 2 ]. The meta-analysis revealed a statistically significant reduction in for unscheduled intravenous infusion for participants receiving reduced osmolarity oral rehydration solution (ORS) when compared with WHO standard ORS was demonstrated (odds ratio 0.62, 95% CI 0.47 to 0.83). For the outcome of children vomiting during diarrhea, the data was available from 5 clinical trials (n=1267) [ Figure 5 ]. The meta-analysis showed that children in the low osmolar ORS group were less likely to vomit that children in WHO standard ORS group (odds ratio 0.74, 95% CI 0.57 to 0.97).
Discussion
The present systematic review and meta-analysis observes the superiority of low osmolar ORS in comparison to WHO standard ORS in children suffering from diarrhea. The low osmolar ORS was observed to have beneficial effect in reducing stool output, unscheduled intravenous infusion and episodes of vomiting. Although, there was no difference observed in duration of diarrhea in children being treated with either ORS formulations. We intended to do subgroup analysis between patients with cholera and non-cholera diarrhea, but there was insufficient data to do so. We could not assess publication bias through funnels plots as the number of clinical trials were small to arrive at an opinion on that. Placebo-controlled double blind Randomized Controlled Trials are required to study the use of reduced osmolarity ORS in diarrhea due to cholera as diarrhea due to cholera is secretory in nature. Oral Rehydration Solution (ORS), along with Zinc tablets, is now used as the first line of therapy to prevent dehydration due to diarrhea. ORS has got a significant amount of public health importance due to its very wide reach in terms of its use till the village health worker level. Thereby, it becomes necessary to document the effectiveness of different forms of ORS being used currently. The current review reflects, supplements and updates the existing knowledge on low osmolar ORS. Policy makers have now shifted to the reduced osmolarity ORS for preventing dehydration due to diarrhea even in areas where cholera coexists with other diarrheas. WHO and UNICEF now recommend the use of low osmolar ORS (245 mOsm/L) for preventing dehydration due to diarrhea. Conclusion Low osmolar ORS when compared to standard WHO-ORS is associated with reduced stool output, reduction in need for unscheduled intravenous infusion and lesser episodes of vomiting. However, there was no significant difference in duration of diarrhea.
Key Messages
Low osmolar ORS, instead of WHO standard ORS, should be used to prevent dehydration in children suffering from diarrhea.
